Livingston Group Asset Management CO operating as Southport Capital Management Has $1.31 Million Holdings in Medtronic PLC (MDT)

Livingston Group Asset Management CO operating as Southport Capital Management cut its stake in Medtronic PLC (NYSE:MDT) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,360 shares of the medical technology company’s stock after selling 1,052 shares during the period. Livingston Group Asset Management CO operating as Southport Capital Management’s holdings in Medtronic were worth $1,308,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc boosted its position in shares of Medtronic by 1.1% in the third quarter. Vanguard Group Inc now owns 109,447,687 shares of the medical technology company’s stock worth $10,766,369,000 after acquiring an additional 1,199,118 shares during the last quarter. BlackRock Inc. boosted its position in shares of Medtronic by 1.5% in the fourth quarter. BlackRock Inc. now owns 98,921,138 shares of the medical technology company’s stock worth $8,997,868,000 after acquiring an additional 1,487,997 shares during the last quarter. Bank of New York Mellon Corp boosted its position in shares of Medtronic by 1.3% in the fourth quarter. Bank of New York Mellon Corp now owns 17,225,948 shares of the medical technology company’s stock worth $1,566,873,000 after acquiring an additional 213,593 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Medtronic by 10.2% in the fourth quarter. Geode Capital Management LLC now owns 16,690,207 shares of the medical technology company’s stock worth $1,515,557,000 after acquiring an additional 1,538,130 shares during the last quarter. Finally, Northern Trust Corp boosted its position in shares of Medtronic by 4.3% in the fourth quarter. Northern Trust Corp now owns 16,526,215 shares of the medical technology company’s stock worth $1,503,225,000 after acquiring an additional 688,537 shares during the last quarter. 81.50% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts recently issued reports on the stock. Barclays reissued a “buy” rating and issued a $104.00 target price on shares of Medtronic in a research report on Wednesday, February 20th. Oppenheimer set a $104.00 target price on shares of Medtronic and gave the stock a “buy” rating in a research report on Wednesday, February 20th. Citigroup raised their target price on shares of Medtronic from $95.00 to $101.00 and gave the stock a “neutral” rating in a research report on Monday, February 25th. Northland Securities restated a “hold” rating and issued a $84.00 price target on shares of Medtronic in a report on Monday, March 18th. Finally, Wells Fargo & Co cut their price target on shares of Medtronic from $101.00 to $100.00 and set a “market perform” rating on the stock in a report on Thursday, April 4th. Ten equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $103.39.

NYSE MDT opened at $84.22 on Friday. Medtronic PLC has a one year low of $78.29 and a one year high of $100.15. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.92 and a current ratio of 2.36. The company has a market capitalization of $112.95 billion, a P/E ratio of 17.66, a price-to-earnings-growth ratio of 2.21 and a beta of 0.81.

Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, February 19th. The medical technology company reported $1.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.05. The company had revenue of $7.55 billion for the quarter, compared to analyst estimates of $7.53 billion. Medtronic had a net margin of 16.10% and a return on equity of 13.85%. The business’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.17 earnings per share. Equities research analysts predict that Medtronic PLC will post 5.15 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 22nd were paid a dividend of $0.50 per share. The ex-dividend date was Thursday, March 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.37%. Medtronic’s dividend payout ratio is currently 41.93%.

ILLEGAL ACTIVITY NOTICE: “Livingston Group Asset Management CO operating as Southport Capital Management Has $1.31 Million Holdings in Medtronic PLC (MDT)” was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/livingston-group-asset-management-co-operating-as-southport-capital-management-has-1-31-million-holdings-in-medtronic-plc-mdt.html.

Medtronic Profile

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

Further Reading: Federal Reserve

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.